RR International Pharma Journal, ISSN: 3079-4684

About the Journal

The RR International Pharma Journal (RRIPJ), ISSN: 3079-4684 is a premier peer-reviewed, refereed, indexed quarterly journal under the banner of Research Radicals Publication, headquartered in Minsk, Belarus. Dedicated to the advancement of pharmaceutical sciences, RRIPJ is designed to provide a dynamic platform for researchers, scholars, and industry professionals to share innovative insights, cutting-edge research, and developments in the pharmaceutical field.

At the core of our mission is the belief that the pharmaceutical sciences are critical to improving global health outcomes. RRIPJ is committed to promoting rigorous academic research, fostering cross-disciplinary collaboration, and ensuring that groundbreaking work in drug development, biotechnology, pharmacology, and other related fields reaches a global audience.

Our Focus Areas Include, not limited to:

• Pharmaceutical Research & Drug Development
• Pharmacology & Toxicology
• Clinical Pharmacy
• Biotechnology in Pharmaceuticals
• Pharmaceutics & Pharmaceutical Chemistry
• Pharmacokinetics & Pharmacodynamics
• Regulatory Affairs & Quality Control
• Herbal & Traditional Medicines
• Pharmacoeconomics & Pharmaceutical Policy

What Sets Us Apart:

• Rigorous Peer Review: RRIPJ maintains high editorial standards, ensuring that every article undergoes a thorough peer-review process by experts in the field, guaranteeing the reliability and scientific integrity of published content.

• Global Reach: Our journal is accessible to a broad international audience, bridging gaps between academia and the pharmaceutical industry, and promoting global collaboration on critical health and medicine topics.

• Interdisciplinary Approach: We encourage submissions from related disciplines, acknowledging that innovation in pharmaceutical sciences often occurs at the intersection of fields like biotechnology, chemistry, and medicine.

• Open Access: RRIPJ is committed to the open access model, ensuring that all research published is freely available to readers worldwide, fostering the free exchange of ideas and knowledge.

Our Vision for the Future: As the flagship journal of Research Radicals Publication, RRIPJ envisions becoming a leader in pharmaceutical publishing, known for contributing significantly to advancements in drug discovery and healthcare. With our plans to expand into other scientific disciplines, RRIPJ represents the first step in building a comprehensive academic publishing platform that caters to researchers and practitioners across a wide range of fields.

Here are some basic details of RRIPJ :

• RRIPJ :  RR International Pharma Journal
• ISSN: 3079-4684
• Chief Editor: Dr. Alexander Petrov, UK
• Publisher:  Research Radicals, Hong Kong
• Starting Year: 2023
• Frequency: Quarterly [4 issues per year]
• Languages: Multiple Languages
• Accessibility: Open Access
• Crossref DOI Prefix: 10.XXXXXX
• Peer Review Process: Double Blind Peer Review Process
• Subject: Pharmacy
• Plagiarism Checker: Turnitin 
• Publication Format: Online
• Contact No.: +852-23591000
• Email: researchradicals@gmail.com 
• Website: https://pharmajournal.org
• Address : 28/P, 1063 King's Road, Quarry Bay, Hong Kong S.A.R.

Key Features of RRIPJ

• Journal listed in Google Scholar
• Indexed with Crossref DOI
• Journal Publishes online on continuous basis
• Online article submission
• Standard double blind peer review process

Join us in shaping the future of pharmaceutical sciences by contributing to and reading the RR International Pharma Journal —where innovation meets impact.